Dr. Robin Carhart-Harris, Ralph Metzner Distinguished Professor at UCSF, is a leading voice in psychedelic research. He discusses the brain's default mode network and its significance in consciousness. The conversation highlights the transformative potential of psychedelics compared to traditional medications, the complexities of therapeutic applications, and the need for a supportive framework during psychedelic experiences. He also shares insights into his groundbreaking studies on 5-MeO-DMT and the challenges in integrating psychedelics into modern healthcare.
01:03:23
forum Ask episode
web_stories AI Snips
view_agenda Chapters
menu_book Books
auto_awesome Transcript
info_circle Episode notes
question_answer ANECDOTE
Time 100 Recognition
Robin Carhart-Harris was surprised to be named in Time magazine's 100 Next list.
He was concerned about potential professional jealousy but ultimately felt it was nice to be recognized.
insights INSIGHT
Shift in Focus
The focus of psychedelic research has shifted from figures like Timothy Leary to scientists and academics.
This shift emphasizes scientific rigor and research in the current psychedelic renaissance.
insights INSIGHT
Default Mode Network
The default mode network (DMN) is a crucial brain system, especially active during mind-wandering.
Psychedelics disrupt the DMN, leading to changes in brain activity and potentially therapeutic effects.
Get the Snipd Podcast app to discover more snips from this episode
Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America
Robert Whitaker
Robert Whitaker's "Anatomy of an Epidemic" challenges the prevailing psychiatric model for treating mental illness. The book argues that the widespread use of psychiatric drugs has contributed to the rise in mental health problems, rather than alleviating them. Whitaker presents a historical analysis of mental health treatment, highlighting the shift from psychosocial approaches to a primarily biological focus. He emphasizes the complexity of the brain and the limitations of a purely biological approach to mental health. The book advocates for a more holistic and patient-centered approach to mental health care.
How to Change Your Mind
What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence
Michael Pollan
In this book, Michael Pollan delves into the history of psychedelic drugs, from their rise in the 1960s to their current resurgence in medical research. He combines historical and scientific analysis with personal narratives of his own experiences with psychedelics, such as LSD and psilocybin. The book explores how these substances are being used to treat conditions like depression, addiction, and anxiety, and discusses their potential to revolutionize our understanding of the human mind and consciousness. Pollan's work is a blend of science, memoir, and travel writing, offering a nuanced and engaging look at the therapeutic and spiritual benefits of psychedelics[1][2][4].
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Dr. Robin Carhart-Harris at the inaugural Eudaimonia summit in West Palm Beach. Find full show notes and links here: https://thethirdwave.co/podcast/episode-287/?ref=278 As the founder of the world's first Centre for Psychedelic Research at Imperial College London and now the Ralph Metzner Distinguished Professor at UCSF, Dr. Carhart-Harris shares his research on how psychedelics affect the brain's default mode network. He explains the key differences between psychedelic therapy and traditional psychiatric medications, discusses his current studies examining the role of set and setting, and explores the unique properties of 5-MeO-DMT. The conversation weaves between detailed neuroscience, the challenges of integrating psychedelics into healthcare, and personal reflections on his 20-year commitment to advancing psychedelic research. Prof Carhart-Harris holds the Ralph Metzner Distinguished Professorship in Neurology and Psychiatry at University of California, San Francisco (UCSF), where he founded the Carhart-Harris Lab in 2023. His groundbreaking research includes human neuroimaging studies with LSD, psilocybin, MDMA, and DMT, along with clinical trials of psilocybin therapy for various disorders. He founded the world's first Centre for Psychedelic Research at Imperial College London in 2019. Named in TIME magazine's '100 Next' in 2021 and Vox Magazine's 'Future 50' in 2023, his current research at UCSF focuses on understanding the mechanisms of psychedelics and psychedelic therapy.
Highlights:
Origins and evolution of psychedelic research in neuroscience
The role of default mode network in consciousness
How psychedelics differ from traditional SSRIs
The relationship between serotonin discovery and LSD research
Challenges of integrating psychedelic therapy into healthcare
Current research projects at UCS
The unique properties of 5-MeO-DMT
Personal reflections on 20 years in psychedelic research
The Psychedelic Podcast 
